J Pediatr Hematol Oncol. 2009 Nov;31(11):873-8.

Decision analysis of treatment strategies in children with severe sickle cell disease.

Source

Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. sarah.obrien@nationwidechildrens.org

Abstract

We designed a decision analysis model comparing 4 treatment strategies for severe sickle cell disease: no intervention, hydroxyurea (HU), chronic transfusion, or stem cell transplant (SCT). The treatment strategy associated with the highest average utility (quality of life) was SCT (0.85). Average utilities for no treatment, chronic transfusion, and HU were 0.68, 0.71, and 0.80, respectively. Our model was quite sensitive to quality-of-life estimates, indicating that a true comparison of HU and transplantation cannot occur until investigators directly measure the health-related quality of life in children with sickle cell disease during HU therapy and after SCT.

PMID:: 19829150; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Comparative Study

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Sickle Cell Anemia - MedlinePlus Health Information

Molecular Biology Databases

HYDROXYUREA - HSDB

Supplemental Content

Related citations

Therapy preference and decision-making among patients with severe sickle cell anemia and their families. [Pediatr Blood Cancer. 2007]
Therapy preference and decision-making among patients with severe sickle cell anemia and their families.
Hankins J, Hinds P, Day S, Carroll Y, Li CS, Garvie P, Wang W. Pediatr Blood Cancer. 2007 Jun 15; 48(7):705-10.
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. [Blood. 1999]
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, et al. Blood. 1999 Sep 1; 94(5):1550-4.
Review Principles and indications of chronic transfusion therapy for children with sickle cell disease. [Clin Adv Hematol Oncol. 2007]
Review Principles and indications of chronic transfusion therapy for children with sickle cell disease.
Ware R. Clin Adv Hematol Oncol. 2007 Sep; 5(9):686-8.
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. [Medicine (Baltimore). 1996]
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP. Medicine (Baltimore). 1996 Nov; 75(6):300-26.
Review Sickle cell disease. [Pediatr Clin North Am. 2002]
Review Sickle cell disease.
Fixler J, Styles L. Pediatr Clin North Am. 2002 Dec; 49(6):1193-210, vi.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Decision analysis of treatment strategies in children with severe sickle cell di...
Decision analysis of treatment strategies in children with severe sickle cell disease.
J Pediatr Hematol Oncol. 2009 Nov ;31(11):873-8.

PubMed
Distribution and functional impact of DNA copy number variation in the rat.
Distribution and functional impact of DNA copy number variation in the rat.
Nat Genet. 2008 May ;40(5):538-45.

PubMed
Prefrontal cortex activity during flexible categorization.
Prefrontal cortex activity during flexible categorization.
J Neurosci. 2010 Jun 23 ;30(25):8519-28.

PubMed
Trends in number of hysterectomies performed in England for menorrhagia: examina...
Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3.
BMJ. 2005 Apr 23 ;330(7497):938-9. Epub 2005 Feb 4 .

PubMed
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine syste...
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
JAMA. 2004 Mar 24 ;291(12):1456-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: